Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease intrahepatic cholangiocarcinoma
Phenotype C0011847|diabetes
Sentences 1
PubMedID- 25980580 Although we acknowledge that the current study does not address the efficacy of metformin against cancer cell models naturally bearing clinically relevant idh1 mutations, our findings provide a direct mechanistic link to the association between metformin use and a significant reduction in incidence of intrahepatic cholangiocarcinoma (ihcc) in patients with diabetes [87].

Page: 1